Eui‐Cheol Shin

15.7k total citations · 1 hit paper
279 papers, 9.6k citations indexed

About

Eui‐Cheol Shin is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Eui‐Cheol Shin has authored 279 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Immunology, 71 papers in Oncology and 65 papers in Epidemiology. Recurrent topics in Eui‐Cheol Shin's work include Immune Cell Function and Interaction (95 papers), T-cell and B-cell Immunology (60 papers) and Cancer Immunotherapy and Biomarkers (46 papers). Eui‐Cheol Shin is often cited by papers focused on Immune Cell Function and Interaction (95 papers), T-cell and B-cell Immunology (60 papers) and Cancer Immunotherapy and Biomarkers (46 papers). Eui‐Cheol Shin collaborates with scholars based in South Korea, United States and Japan. Eui‐Cheol Shin's co-authors include Su‐Hyung Park, Pil Soo Sung, Jeong Seok Lee, Barbara Rehermann, Min‐Seok Rha, Min Kyung Jung, Sungha Park, You‐Me Kim, Seong Jin Choi and Vito Racanelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Eui‐Cheol Shin

267 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

2020 530 citations Hye Won Jeong, Seong Jin Choi et al. Science Immunology profile →

Peers

Countries citing papers authored by Eui‐Cheol Shin

Since Specialization

Citations

This map shows the geographic impact of Eui‐Cheol Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eui‐Cheol Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eui‐Cheol Shin more than expected).

Fields of papers citing papers by Eui‐Cheol Shin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eui‐Cheol Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eui‐Cheol Shin. The network helps show where Eui‐Cheol Shin may publish in the future.

Co-authorship network of co-authors of Eui‐Cheol Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Eui‐Cheol Shin. A scholar is included among the top collaborators of Eui‐Cheol Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eui‐Cheol Shin. Eui‐Cheol Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients With Mild COVID-19 Exhibit Low Functional Avidity of SARS-CoV-2 Membrane Protein-Reactive CD4⁺ T Cells 2025 ·Immune Network ·(unknown), June‐Young Koh, Min‐Seok Rha, (unknown), Jae‐Hoon Ko, Hee Kyoung Choi, Ji Hoon Jeon, Hyeri Seok, Dae Won Park, Kyong Ran Peck, Jun Yong Choi, Su‐Hyung Park, Won Suk Choi, Hye Won Jeong, Eui‐Cheol Shin	0
2	Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma 2024 ·Journal for ImmunoTherapy of Cancer ·Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Yu Ri Kim, (unknown), Yeon-Hee Kim, June‐Won Cheong, Jennifer N. Wu, Eui‐Cheol Shin, Hyunsoo Cho, Jin Seok Kim	5
3	SARS-CoV-2 vaccine-elicited immune responses in solid organ transplant recipients 2024 ·SHILAP Revista de lepidopterología ·Euri Seo, Eui‐Cheol Shin, (unknown)	0
4	Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade 2024 ·Clinical Cancer Research ·Seung Hyuck Jeon, (unknown), Junsik Park, (unknown), (unknown), (unknown), (unknown), (unknown), Woo‐Chan Son, (unknown), Eui‐Cheol Shin, Jung‐Yun Lee, Dai Hoon Han, Jaeho Jung, Su‐Hyung Park	6
5	CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy 2023 ·Clinical Cancer Research ·Seung Hyuck Jeon, Minyong Kang, (unknown), (unknown), (unknown), Yong Joon Lee, (unknown), (unknown), Junsik Park, Jung‐Yun Lee, Eui‐Cheol Shin, Seong Il Seo, Su‐Hyung Park	10
6	COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B 2023 ·Immune Network ·(unknown), (unknown), Ji Yun Noh, June‐Young Koh, (unknown), (unknown), Sung Won Chung, (unknown), Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jae‐Hoon Ko, Kyong Ran Peck, Joon Young Song, Eui‐Cheol Shin, Jeong‐Hoon Lee	1
7	Human CD8⁺ T-Cell Populations That Express Natural Killer Receptors 2023 ·Immune Network ·June‐Young Koh, Dong-Uk Kim, (unknown), Eui‐Cheol Shin	15
8	A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity 2023 ·Nature Immunology ·Joon Seok, Sung‐Dong Cho, (unknown), (unknown), Su‐Young Kim, Sungmin Lee, (unknown), Seongju Jeong, (unknown), Hoyoung Lee, (unknown), Baekgyu Choi, Sang‐Jun Ha, Inkyung Jung, Ki‐Jun Yoon, Jong-Eun Park, Jong Hoon Kim, Beom Joon Kim, Eui‐Cheol Shin, Su‐Hyung Park	20
9	CD39 ⁺ tissue-resident memory CD8 ⁺ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer 2022 ·Science Immunology ·Yong Joon Lee, Jee Ye Kim, Seung Hyuck Jeon, (unknown), Jae Hyung Jung, (unknown), (unknown), Soong June Bae, (unknown), Tae-Kyung Yoo, Woo Young Sun, Sung Gwe Ahn, Joon Jeong, Su‐Hyung Park, Woo Chan Park, Seung Il Kim, Eui‐Cheol Shin	34
10	An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21 2022 ·npj Vaccines ·(unknown), Sung Joon Hong, (unknown), Jiyeon Kim, (unknown), Corey Casper, Darrick Carter, Steven G. Reed, (unknown), Eui‐Cheol Shin	16
11	Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma 2021 ·Clinical Cancer Research ·Hyunsoo Cho, Kyung Hwan Kim, Hoyoung Lee, Chang Gon Kim, Haerim Chung, Yoon Seok Choi, Su‐Hyung Park, June‐Won Cheong, Yoo Hong Min, Eui‐Cheol Shin, Jin Seok Kim	31
12	PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors 2020 ·Clinical Cancer Research ·Minsuk Kwon, (unknown), Hoyoung Lee, Hyunsoo Cho, (unknown), (unknown), Seong Jin Choi, Junsik Park, In‐Ho Seo, Bjarne Bogen, Ik‐Chan Song, Deog‐Yeon Jo, Jin Seok Kim, Su‐Hyung Park, Inhak Choi, Yoon Seok Choi, Eui‐Cheol Shin	34
13	The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses 2020 ·Viruses ·Eui‐Cheol Shin, Ji Won Han, Wonseok Kang, Takanobu Kato, Seong‐Jun Kim, Jin Zhong, Seungtaek Kim, (unknown), Pil Soo Sung, Koichi Watashi, Jun Yong Park, Marc P. Windisch, Jong‐Won Oh, Takaji Wakita, Kwang‐Hyub Han, Sung Key Jang	3
14	The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors 2019 ·Clinical Cancer Research ·Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, Jiae Koh, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Jaekyung Cheon, Young Joo Min, Su‐Hyung Park, Keunchil Park, Myung‐Ju Ahn, Eui‐Cheol Shin	132
15	Increased frequency of CD4+CD57+ senescent T cells in patients with newly diagnosed acute heart failure: exploring new pathogenic mechanisms with clinical relevance 2019 ·Scientific Reports ·Jong‐Chan Youn, Min Kyung Jung, Hee Tae Yu, Ji‐Soo Kwon, Jeong-Eun Kwak, Su‐Hyung Park, In‐Cheol Kim, Myung Soo Park, (unknown), (unknown), Seongwoo Han, Kyu-Hyung Ryu, Seok‐Min Kang, Eui‐Cheol Shin	35
16	Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax® in healthy adults aged 50 years and older 2019 ·Vaccine ·Won Suk Choi, Jung‐Hyun Choi, Dong Sik Jung, Hee Jung Choi, Kim Ys, Jacob Lee, Hee‐Chang Jang, Eui‐Cheol Shin, (unknown), Hun Kim, Hee Jin Cheong	7
17	YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma 2018 ·Cancer Immunology Research ·Min Hwan Kim, Chang Gon Kim, Sang Kyum Kim, Sang Joon Shin, Eun‐Ah Choe, Su‐Hyung Park, Eui‐Cheol Shin, Joon Kim	175
18	Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses 2017 ·Journal of Controlled Release ·Sukmo Kang, Sukyung Ahn, Jeewon Lee, Jin Yong Kim, Minsuk Choi, Vipul Gujrati, Hyungjun Kim, Jinjoo Kim, Eui‐Cheol Shin, Sangyong Jon	127
19	Immunologic Characterization of Tumor Antigen-Specific T Cells in Multiple Myeloma: Implication in Immune Checkpoint Blockade 2017 ·Blood ·Yoon Seok Choi, Minsuk Kwon, Ik‐Chan Song, Hyo Jin Lee, Hwan‐Jung Yun, Deog‐Yeon Jo, Eui‐Cheol Shin	1
20	Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions 2004 ·Blood ·Michelina Nascimbeni, Eui‐Cheol Shin, Luis Chiriboga, David E. Kleiner, Barbara Rehermann	210

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact